Neogen Q1 Revenue Rises 6.5%; Raises FY27 Outlook
Neogen Corp. (NEOG) reported a 6.5% revenue increase to $222.8M in Q1 FY27, with an adjusted net income of $17.5M. The company raised its FY27 revenue guidance to $885M-$890M and adjusted EBITDA to $181M-$183M. It also announced a collaboration with Hinalea Imaging and plans to sell its Genomics business to Zoetis Inc.
How this was made
The 30-second read
Why it matters
The raised guidance reflects confidence in upcoming product launches and a strategic partnership with Hinalea Imaging.
Market read
Earnings beat and guidance lift are primary catalysts for NEOG's near‑term price action.
What to watch
Potential regulatory delays for new imaging technology could temper upside.
Background
Neogen is a provider of food safety, livestock, and pet wellness solutions, recently expanding into digital imaging.
Ticker impact
Neogen reported Q1 revenue up 6.5% and raised FY27 revenue and EBITDA guidance.
likely upward pressure as investors price in higher revenue outlook
Guidance lift is a fresh, material fact that can move the stock in after‑hours trading.
Market effects
Food safety and testing sector may see renewed investor interest.
U.S. biotech and specialty chemicals markets could benefit from higher guidance.
Limited to companies with similar food safety product lines.
Counterpoint
Guidance raise may already be priced in; execution risk remains.
Key entities
- companyNeogen Corp.
Food safety solutions provider.
- companyHinalea Imaging Corp.
Partner for hyperspectral imaging technology.
